Clinical Evaluation Of Ventricular Septal Defect (VSD) In Children at Sohag Univesity Hospital

July 8, 2024 updated by: Amany Sabry Thabet, Sohag University

Clinical Evaluation Of Ventricular Septal Defect (VSD) in Children at Sohag University Hospital

ventricular septal defect(VSD) are one of the most common significant CHD and account for up to 40% of all cardiac abnormalities.VSD is commonly isolated defect as well as intrinsic component of several complex cardiac malformations including tetrology of fallot ,double- outlet right ventricle(RV),transposition of great vessles,aortic coartication or interruption ,and truncus arteriosus

Study Overview

Status

Recruiting

Conditions

Ventricular Septal Defect

Intervention / Treatment

Device: ECHO

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Name: mohamed A mohamed, Professor

Study Contact Backup

Name: amany S Thabit, Resident
Phone Number: 01200074781
Email: amany.saber@med.sohag.edu.eg

Study Locations

Egypt
- - Sohag, Egypt
    - Recruiting
    - Sohag University Hospitals
    - Contact:
      
      Magdy M Amin, professor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

Child

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

all children from date of birth to age of 16 years old including both genders diagnosed to have isolated VSD or apart from another cardiac anomalies

Description

Inclusion Criteria:

all children from date of birth to age of 16 years old including both genders diagnosed to have isolated VSD or apart from another cardiac anomalies

Exclusion Criteria:

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
size of VSD Time Frame: 12 months	size of VSD in mm according echocardiology	12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sohag University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 24, 2024

Primary Completion (Estimated)

June 24, 2025

Study Completion (Estimated)

June 24, 2025

Study Registration Dates

First Submitted

July 1, 2024

First Submitted That Met QC Criteria

July 8, 2024

First Posted (Actual)

July 9, 2024

Study Record Updates

Last Update Posted (Actual)